The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells

Selenium in Radiation Oncology—15 Years of Experiences in Germany

(2018) Ralph Muecke et al.   Nutrients

Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development*

(2018) Yousef Zakharia et al.   Oncotarget

Comparative Safety and Pharmacokinetic Evaluation of Three Oral Selenium Compounds in Cancer Patients

(2018) Stephen O. Evans et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Phase I trial of selenium plus chemotherapy in gynecologic cancers

(2018) Mihae Song et al.   GYNECOLOGIC ONCOLOGY

Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance

(2017) Richard J. Lobb et al.   INTERNATIONAL JOURNAL OF CANCER

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial

(2017) David R Freyer et al.   LANCET ONCOLOGY

Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men

(2017) James R. Marshall et al.   Oncotarget

Appraisal of biochemical classes of radioprotectors: evidence, current status and guidelines for future development

(2017) Krishnanand Mishra et al.   3 Biotech

Appraisal of biochemical classes of radioprotectors: evidence, current status and guidelines for future development

(2017) Krishnanand Mishra et al.   3 Biotech

Glutathione-Associated Enzymes In Anticancer Drug Resistance

(2016) K. D. Tew   CANCER RESEARCH

Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid

(2016) Claudia Lennicke et al.   OncoImmunology

Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells

(2015) M. Liu et al.   BIOSCIENCE REPORTS

Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study

(2015) Ola Brodin et al.   Nutrients

Updates on clinical studies of selenium supplementation in radiotherapy

(2014) Irma M Puspitasari et al.   Radiation Oncology

The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial

(2013) Z Jahangard-Rafsanjani et al.   BONE MARROW TRANSPLANTATION

Selenium and human health

(2012) Margaret P Rayman   LANCET

Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines

(2011) Shireen Kassam et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Intracellular glutathione content influences the sensitivity of lung cancer cell lines to methylseleninic acid

(2011) Chengfei Liu et al.   MOLECULAR CARCINOGENESIS

Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer

(2010) N M Corcoran et al.   BRITISH JOURNAL OF CANCER

Multicenter, Phase 3 Trial Comparing Selenium Supplementation With Observation in Gynecologic Radiation Oncology

(2010) Ralph Muecke et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

In vitro evaluation of selenium genotoxic, cytotoxic, and protective effects: a review

(2009) Vanessa Valdiglesias et al.   ARCHIVES OF TOXICOLOGY

High-Dose Sodium Selenite Can Induce Apoptosis of Lymphoma Cells in Adult Patients with Non-Hodgkin’s Lymphoma

(2008) Inas A. Asfour et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells

(2008) Z. Li et al.   MOLECULAR CANCER THERAPEUTICS